GLP-1微剂量使用者追求更长寿

Some people aren’t waiting around for data. That includes many patients of Shamsah Amersi, an ob-gyn in Santa Monica, Calif. Amersi discusses microdosing with all patients entering perimenopause, she says, and about 60 percent of her patients over 40 use a GLP-1 drug this way. Though the medications aren't right for everybody, she says, the majority of microdosers under her care feel better and see improvements on lab tests measuring metabolic and overall health. “GLP-1 is one of the most transformative therapies in modern medicine,” Amersi says. She thinks patients can benefit from microdosing now, even without data to prove its efficacy, if they work with a doctor to carefully monitor their response. …